VGKC antibodies in pediatric encephalitis presenting with status epilepticus
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Background: Voltage-gated potassium channel antibodies (VGKC Ab) are associated with limbic encephalitis and neuromyotonia in adults. There have been no systematic investigations in children to date.
Methods: We looked for antibodies that are associated with CNS syndromes in adults including antibodies to VGKCs, NMDARs, glutamic acid decarboxylase (GAD), and glycine receptor (GlyR) in the stored acute serum from 10 children with unexplained encephalitis presenting with encephalopathy and status epilepticus. We also looked for antibodies to leucine-rich glioma-inactivated 1 (Lgi1) and contactin-associated protein-like 2 (Caspr2), which are now known to be tightly complexed with VGKCs in vivo. Sixty-nine pediatric controls were used for comparison.
Results: An elevated VGKC Ab (>100 pM) was detected in 4/10 patients with encephalitis compared to only 1/69 controls (p < 0.001). The outcome in the 4 VGKC Ab-positive patients with encephalitis was variable including good recovery (n = 1), cognitive impairment (n = 3), temporal lobe epilepsy (n = 2), and mesial temporal sclerosis (n = 1). No other antibodies were detected, including those to Lgi1 and Caspr2.
Conclusion: Encephalitis associated with VGKC Ab occurs in children and presents with status epilepticus and focal epilepsy. These antibodies are not directed against Lgi1 or Caspr2.
Footnotes
-
Supplemental data at www.neurology.org
-
- Ab
- antibody
- AERRPS
- acute encephalitis with refractory, repetitive partial seizures
- Caspr2
- contactin-associated protein-like 2
- DESC
- devastating epileptic encephalopathy in school-aged children
- GAD
- glutamic acid decarboxylase
- GlyR
- glycine receptor
- ICU
- intensive care unit
- IgG
- immunoglobulin G
- IgM
- immunoglobulin M
- LE
- limbic encephalitis
- Lgi1
- leucine-rich glioma-inactivated 1
- SE
- status epilepticus
- TLE
- temporal lobe epilepsy
- VGKC
- voltage-gated potassium channel
- Received August 2, 2010.
- Accepted December 22, 2010.
- Copyright © 2011 by AAN Enterprises, Inc.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Utility of an immunotherapy trial in evaluating patients with presumed autoimmune epilepsyM. Toledano, J.W. Britton, A. McKeon et al.Neurology, April 04, 2014 -
Views and Reviews
Encephalitis and antibodies to synaptic and neuronal cell surface proteinsEric Lancaster, Eugenia Martinez-Hernandez, Josep Dalmau et al.Neurology, July 11, 2011 -
Articles
Serum antibodies in epilepsy and seizure-associated disordersK. McKnight, Y. Jiang, Y. Hart et al.Neurology, December 12, 2005 -
Article
Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patientTania Cellucci, Heather Van Mater, Francesc Graus et al.Neurology: Neuroimmunology & Neuroinflammation, January 17, 2020